Clinical Trial Update: Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of amimestrocel, a mesenchymal stromal cell therapy, in diabetic kidney disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• Amimestrocel (mesenchymal stromal cells)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Diabetic Kidney Disease (DKD) | Phase 2 | Status: RECRUITING